Weiner LM - Search Results

1

Induction of adaptive Anti-HER2/neu immune responses in a Phase 1B/2 trial of 2B1 bispecific murine monoclonal antibody in metastatic breast cancer (E3194): a trial coordinated by the Eastern Cooperative Oncology Group.

Borghaei H, Alpaugh RK, Bernardo P, Palazzo IE, Dutcher JP, Venkatraj U, Wood WC, Goldstein L, Weiner LM. Borghaei H, et al. Among authors: weiner lm. J Immunother. 2007 May-Jun;30(4):455-67. doi: 10.1097/CJI.0b013e31803bb421. J Immunother. 2007. PMID: 17457220 Clinical Trial.

2

Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.

Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM. Garcia de Palazzo I, et al. Among authors: weiner lm. Cancer Res. 1992 Oct 15;52(20):5713-9. Cancer Res. 1992. PMID: 1394194

3

Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

Weiner LM, O'Dwyer J, Kitson J, Comis RL, Frankel AE, Bauer RJ, Konrad MS, Groves ES. Weiner LM, et al. Cancer Res. 1989 Jul 15;49(14):4062-7. Cancer Res. 1989. PMID: 2786751 Clinical Trial.

4

Effector characteristics of the IgG3 murine monoclonal antibody 113F1.

Weiner LM, Zarou CM, O'Brien J, Ring D. Weiner LM, et al. J Biol Response Mod. 1989 Jun;8(3):227-37. J Biol Response Mod. 1989. PMID: 2787391

5

Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.

Weiner LM, Moldofsky PJ, Gatenby RA, O'Dwyer J, O'Brien J, Litwin S, Comis RL. Weiner LM, et al. Cancer Res. 1988 May 1;48(9):2568-73. Cancer Res. 1988. PMID: 3128400

6

Biologic treatment of human cancer.

Clark JI, Weiner LM. Clark JI, et al. Among authors: weiner lm. Curr Probl Cancer. 1995 Jul-Aug;19(4):185-262. Curr Probl Cancer. 1995. PMID: 7489640 Review.

7

Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

Weiner LM, Clark JI, Davey M, Li WS, Garcia de Palazzo I, Ring DB, Alpaugh RK. Weiner LM, et al. Cancer Res. 1995 Oct 15;55(20):4586-93. Cancer Res. 1995. PMID: 7553634 Clinical Trial.

8

CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor.

Saleh MN, Goldman SJ, LoBuglio AF, Beall AC, Sabio H, McCord MC, Minasian L, Alpaugh RK, Weiner LM, Munn DH. Saleh MN, et al. Among authors: weiner lm. Blood. 1995 May 15;85(10):2910-7. Blood. 1995. PMID: 7742551 Free article. Clinical Trial.

9

Immunohistochemical detection of c-erbB-2 expression by neoplastic human tissue using monospecific and bispecific monoclonal antibodies.

Garcia de Palazzo I, Klein-Szanto A, Weiner LM. Garcia de Palazzo I, et al. Among authors: weiner lm. Int J Biol Markers. 1993 Oct-Dec;8(4):233-9. doi: 10.1177/172460089300800406. Int J Biol Markers. 1993. PMID: 7908024

10

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK. Weiner LM, et al. Cancer Res. 1994 Aug 1;54(15):4084-90. Cancer Res. 1994. PMID: 8033141 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

302 results

Search Page